Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings
Document Type
Letter to the Editor
Publication Date
2-21-2026
Journal
The American journal of medicine
DOI
10.1016/j.amjmed.2026.01.035
APA Citation
Raman, Venkatesh K.; Vargas, Jose D.; Moore, Hans J.; Wu, Wen-Chih; Patel, Samir S.; Zhang, Sijian; Morgan, Charity J.; Lam, Phillip H.; Heidenreich, Paul A.; Lu, Frederick; Ahmed, Amiya A.; Fonarow, Gregg C.; and Ahmed, Ali, "Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings" (2026). GW Authored Works. Paper 8683.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8683
Department
Medicine
COinS